Generation of human MHC (HLA-A11/DR1) transgenic mice for vaccine evaluation

References

• Viret C, Janeway CA, Jr. MHC and T cell development. Rev Immunogenet 1999; 1:91-104; PMID:11256575
   PubMedGoogle Scholar
• Sprent J, Gao EK, Webb SR. T cell reactivity to MHC molecules: immunity versus tolerance. Science 1990; 248:1357-63; PMID:1694041; http://dx.doi.org/10.1126/science.1694041
   PubMed Web of Science ®Google Scholar
• Sette A, Fikes J. Epitope-based vaccines: an update on epitope identification, vaccine design and delivery. Curr Opin Immunol 2003; 15:461-70; PMID:12900280; http://dx.doi.org/10.1016/S0952-7915(03)00083-9
   PubMed Web of Science ®Google Scholar
• Sette A, Livingston B, McKinney D, Appella E, Fikes J, Sidney J, Newman M, Chesnut R. The development of multi-epitope vaccines: epitope identification, vaccine design and clinical evaluation. Biologicals 2001; 29:271-6; PMID:11851327; http://dx.doi.org/10.1006/biol.2001.0297
   PubMed Web of Science ®Google Scholar
• Comber JD, Philip R. MHC class I antigen presentation and implications for developing a new generation of therapeutic vaccines. Ther Adv Vaccines 2014; 2:77-89; PMID:24790732; http://dx.doi.org/10.1177/2051013614525375
   PubMedGoogle Scholar
• Pulendran B, Ahmed R. Immunological mechanisms of vaccination. Nat Immunol 2011; 12:509-17; PMID:21739679; http://dx.doi.org/10.1038/ni.2039
   PubMed Web of Science ®Google Scholar
• Demento SL, Siefert AL, Bandyopadhyay A, Sharp FA, Fahmy TM. Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines. Trends Biotechnol 2011; 29:294-306; PMID:21459467; http://dx.doi.org/10.1016/j.tibtech.2011.02.004
   PubMed Web of Science ®Google Scholar
• Oyarzun P, Ellis JJ, Gonzalez-Galarza FF, Jones AR, Middleton D, Boden M, Kobe B. A bioinformatics tool for epitope-based vaccine design that accounts for human ethnic diversity: application to emerging infectious diseases. Vaccine 2015; 33:1267-73; PMID:25629524; http://dx.doi.org/10.1016/j.vaccine.2015.01.040
   PubMed Web of Science ®Google Scholar
• Himoudi N, Abraham JD, Fournillier A, Lone YC, Joubert A, Op De Beeck A, Freida D, Lemonnier F, Kieny MP, Inchauspé G. Comparative vaccine studies in HLA-A2.1-transgenic mice reveal a clustered organization of epitopes presented in hepatitis C virus natural infection. J Virol 2002; 76:12735-46; PMID:12438599; http://dx.doi.org/10.1128/JVI.76.24.12735-12746.2002
   PubMed Web of Science ®Google Scholar
• Healey GD, Elvin SJ, Morton M, Williamson ED. Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection. Infect Immun 2005; 73:5945-51; PMID:16113315; http://dx.doi.org/10.1128/IAI.73.9.5945-5951.2005
   PubMed Web of Science ®Google Scholar
• Raffegerst SH, Hoelzlwimmer G, Kunder S, Mysliwietz J, Quintanilla-Martinez L, Schendel DJ. Diverse hematological malignancies including hodgkin-like lymphomas develop in chimeric MHC class II transgenic mice. PLoS One 2009; 4:e8539; PMID:20046882; http://dx.doi.org/10.1371/journal.pone.0008539
   PubMedGoogle Scholar
• Boesen A, Sundar K, Coico R. Lassa fever virus peptides predicted by computational analysis induce epitope-specific cytotoxic-T-lymphocyte responses in HLA-A2.1 transgenic mice. Clin Diagn Lab Immunol 2005; 12:1223-30; PMID:16210487
   PubMedGoogle Scholar
• Ishioka GY, Fikes J, Hermanson G, Livingston B, Crimi C, Qin M, del Guercio MF, Oseroff C, Dahlberg C, Alexander J, et al. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes. J Immunol 1999; 162:3915-25; PMID:10201910
   PubMed Web of Science ®Google Scholar
• Pajot A, Michel ML, Mancini-Bourgine M, Ungeheuer MN, Ojcius DM, Deng Q, Lemonnier FA, Lone YC. Identification of novel HLA-DR1-restricted epitopes from the hepatitis B virus envelope protein in mice expressing HLA-DR1 and vaccinated human subjects. Microbes Infect 2006; 8:2783-90; PMID:17045504; http://dx.doi.org/10.1016/j.micinf.2006.08.009
   PubMed Web of Science ®Google Scholar
• BenMohamed L, Krishnan R, Longmate J, Auge C, Low L, Primus J, Diamond DJ. Induction of CTL response by a minimal epitope vaccine in HLA A*0201/DR1 transgenic mice: dependence on HLA class II restricted T(H) response. Hum Immunol 2000; 61:764-79; PMID:10980387; http://dx.doi.org/10.1016/S0198-8859(00)00139-7
   PubMed Web of Science ®Google Scholar
• Wasik TJ, Wierzbicki A, Whiteman VE, Trinchieri G, Lischner HW, Kozbor D. Association between HIV-specific T helper responses and CTL activities in pediatric AIDS. Eur J Immunol 2000; 30:117-27; PMID:10602033; http://dx.doi.org/10.1002/1521-4141(200001)30:1%3c117::AID-IMMU117%3e3.0.CO;2-4
   PubMed Web of Science ®Google Scholar
• Pajot A, Michel ML, Fazilleau N, Pancre V, Auriault C, Ojcius DM, Lemonnier FA, Lone YC. A mouse model of human adaptive immune functions: HLA-A2.1-/HLA-DR1-transgenic H-2 class I-/class II-knockout mice. Eur J Immunol 2004; 34:3060-9; PMID:15468058; http://dx.doi.org/10.1002/eji.200425463
   PubMed Web of Science ®Google Scholar
• Ru Z, Xiao W, Pajot A, Kou Z, Sun S, Maillere B, Zhao G, Ojcius DM, Lone YC, Zhou Y. Development of a humanized HLA-A2.1/DP4 transgenic mouse model and the use of this model to map HLA-DP4-restricted epitopes of HBV envelope protein. PLoS One 2012; 7:e32247.
   PubMed Web of Science ®Google Scholar
• Dion S, Bourgine M, Godon O, Levillayer F, Michel ML. Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules. J Virol 2013; 87:5554-63; PMID:23468504; http://dx.doi.org/10.1128/JVI.03134-12
   PubMed Web of Science ®Google Scholar
• Reiser M, Wieland A, Plachter B, Mertens T, Greiner J, Schirmbeck R. The immunodominant CD8 T cell response to the human cytomegalovirus tegument phosphoprotein pp65(495-503) epitope critically depends on CD4 T cell help in vaccinated HLA-A*0201 transgenic mice. J Immunol 2011; 187:2172-80; PMID:21810614; http://dx.doi.org/10.4049/jimmunol.1002512
   PubMed Web of Science ®Google Scholar
• Smith HA, McNeel DG. Vaccines targeting the cancer-testis antigen SSX-2 elicit HLA-A2 epitope-specific cytolytic T cells. J Immunother 2011; 34:569-80; PMID:21904219; http://dx.doi.org/10.1097/CJI.0b013e31822b5b1d
   PubMed Web of Science ®Google Scholar
• Smith HA, Cronk RJ, Lang JM, McNeel DG. Expression and immunotherapeutic targeting of the SSX family of cancer-testis antigens in prostate cancer. Cancer Res 2011; 71:6785-95; PMID:21880588; http://dx.doi.org/10.1158/0008-5472.CAN-11-2127
   PubMed Web of Science ®Google Scholar
• Lee TD, Zhao TM, Mickey R, Sun YP, Lee G, Song CX, Cheng DZ, Zhou S, Ding SQ, Cheng DX, et al. The polymorphism of HLA antigens in the Chinese. Tissue Antigens 1988; 32:188-208; PMID:3217935; http://dx.doi.org/10.1111/j.1399-0039.1988.tb01656.x
   PubMed Web of Science ®Google Scholar
• Alexander J, Oseroff C, Sidney J, Wentworth P, Keogh E, Hermanson G, Chisari FV, Kubo RT, Grey HM, Sette A. Derivation of HLA-A11/Kb transgenic mice: functional CTL repertoire and recognition of human A11-restricted CTL epitopes. J Immunol 1997; 159:4753-61; PMID:9366399
   PubMed Web of Science ®Google Scholar
• Weiskopf D, Yauch LE, Angelo MA, John DV, Greenbaum JA, Sidney J, Kolla RV, De Silva AD, de Silva AM, Grey H, et al. Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design. J Immunol 2011; 187:4268-79; PMID:21918184; http://dx.doi.org/10.4049/jimmunol.1101970
   PubMed Web of Science ®Google Scholar
• Ureta-Vidal A, Firat H, Perarnau B, Lemonnier FA. Phenotypical and functional characterization of the CD8+ T cell repertoire of HLA-A2.1 transgenic, H-2Kb null Db null double knockout mice. J Immunol 1999; 163:2555-60; PMID:10452993
   PubMed Web of Science ®Google Scholar
• Firat H, Cochet M, Rohrlich PS, Garcia-Pons F, Darche S, Danos O, Lemonnier FA, Langlade-Demoyen P. Comparative analysis of the CD8(+) T cell repertoires of H-2 class I wild-type/HLA-A2.1 and H-2 class I knockout/HLA-A2.1 transgenic mice. Int Immunol 2002; 14:925-34; PMID:12147629; http://dx.doi.org/10.1093/intimm/dxf056
   PubMed Web of Science ®Google Scholar
• Liu Y, Luo X, Yang C, Yu S, Xu H. Three CpG oligodeoxynucleotide classes differentially enhance antigen-specific humoral and cellular immune responses in mice. Vaccine 2011; 29:5778-84; PMID:21664398; http://dx.doi.org/10.1016/j.vaccine.2011.05.087
   PubMed Web of Science ®Google Scholar
• Yang Y, Sun W, Guo J, Zhao G, Sun S, Yu H, Guo Y, Li J, Jin X, Du L, et al. In silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations. Hum Vaccin Immunother 2015; 11:795-805; PMID:25839222; http://dx.doi.org/10.1080/21645515.2015.1012017
   PubMed Web of Science ®Google Scholar
• De Groot AS, Jesdale B, Martin W, Saint Aubin C, Sbai H, Bosma A, Lieberman J, Skowron G, Mansourati F, Mayer KH. Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach. Vaccine 2003; 21:4486-504; PMID:14505932; http://dx.doi.org/10.1016/S0264-410X(03)00390-6
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhang M, Cong H. Advances in the study of HLA-restricted epitope vaccines. Hum Vaccin Immunother 2013; 9:2566-77; PMID:23955319; http://dx.doi.org/10.4161/hv.26088
   PubMed Web of Science ®Google Scholar
• Chen HW, Leng CH, Liu HY, Cheng WF, Chang YW, Wu PY, Lien SP, Huang TY, Chiang SK, Lin MH, et al. Identification of HLA-A11-restricted CTL epitopes derived from HPV type 18 using DNA immunization. Cancer Biol Ther 2009; 8:2025-32; PMID:19738415; http://dx.doi.org/10.4161/cbt.8.21.9732
   PubMed Web of Science ®Google Scholar
• Gavioli R, Kurilla MG, de Campos-Lima PO, Wallace LE, Dolcetti R, Murray RJ, Rickinson AB, Masucci MG. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. J Virol 1993; 67:1572-8; PMID:7679748
   PubMed Web of Science ®Google Scholar
• Deng Q, Mancini-Bourgine M, Zhang X, Cumont MC, Zhu R, Lone YC, Michel ML. Hepatitis B virus as a gene delivery vector activating foreign antigenic T cell response that abrogates viral expression in mouse models. Hepatology 2009; 50:1380-91; PMID:19821533; http://dx.doi.org/10.1002/hep.23150
   PubMed Web of Science ®Google Scholar
• Boucherma R, Kridane-Miledi H, Bouziat R, Rasmussen M, Gatard T, Langa-Vives F, Lemercier B, Lim A, Bérard M, Benmohamed L, et al. HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 monochain transgenic/H-2 class I null mice: novel versatile preclinical models of human T cell responses. J Immunol 2013; 191:583-93; PMID:23776170; http://dx.doi.org/10.4049/jimmunol.1300483
   PubMed Web of Science ®Google Scholar
• Pajot A, Schnuriger A, Moris A, Rodallec A, Ojcius DM, Autran B, Lemonnier FA, Lone YC. The Th1 immune response against HIV-1 Gag p24-derived peptides in mice expressing HLA-A02.01 and HLA-DR1. Eur J Immunol 2007; 37:2635-44; PMID:17668896; http://dx.doi.org/10.1002/eji.200636819
   PubMed Web of Science ®Google Scholar
• Ramage JM, Metheringham R, Moss R, Spendlove I, Rees R, Durrant LG. Comparison of the immune response to a self antigen after DNA immunisation of HLA*A201/H-2Kb and HHD transgenic mice. Vaccine 2004;22:1728-31; PMID:15068856; http://dx.doi.org/10.1016/j.vaccine.2004.01.034
   PubMed Web of Science ®Google Scholar
• Firat H, Cochet M, Rohrlich PS, Garcia-Pons F, Darche S, Danos O, Lemonnier FA, Langlade-Demoyen P. Comparative analysis of the CD8(+) T cell repertoires of H-2 class I wild-type/HLA-A2.1 and H-2 class I knockout/HLA-A2.1 transgenic mice. Int Immunol. 2002;14:925-34; PMID:12147629; http://dx.doi.org/10.1093/intimm/dxf056
   PubMed Web of Science ®Google Scholar
• Pascolo S, Bervas N, Ure JM, Smith AG, Lemonnier FA, Perarnau B. HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice. J Exp Med 1997; 185:2043-51; PMID:9182675; http://dx.doi.org/10.1084/jem.185.12.2043
   PubMed Web of Science ®Google Scholar
• Yang C, Shi H, Zhou J, Liang Y, Xu H. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus. Vaccine 2009; 27:6558-63; PMID:19729087; http://dx.doi.org/10.1016/j.vaccine.2009.08.047
   PubMed Web of Science ®Google Scholar